Work

Activity of Moxifloxacin against Mycobacterium tuberculosis in Acid Phase and Nonreplicative-Persister Phenotype Phase in a Hollow-Fiber Infection Model

Year: 2018

Type: article

Abstract: A major goal for improving tuberculosis therapy is to identify drug regimens with improved efficacy and shorter treatment durations. Shorter therapies improve patient adherence to the antibiotic regimens, which, in turn, decreases resistance emergence.

Source: Antimicrobial Agents and Chemotherapy

DOI: 10.1128/aac.01470-18

Authors: Arnold Louie, Brandon Duncanson, Jenny Myrick, Michael Maynard, Jocelyn Nole, David Brown, Stephan Schmidt, Michael Neely, C. A. Scanga, Charles Peloquin, G. L. Drusano

Institutions: University of Florida, University of Florida Health, University of Southern California, Children's Hospital Los Angeles, University of Pittsburgh

Language: English

Topic: Tuberculosis Research and Epidemiology

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funder: National Institute of Allergy and Infectious Diseases

Award: Optimizing Combination Therapy to Accelerate Clinical Cure of Tuberculosis

OpenAlex ID: W2889641677

FWCI: 1.7

Cites: 17

Cited by: 17

Related to: 10